Topics
Sector
Geography
Subject

Videos Library

Event Videos

Medical Affairs Leaders Forum (Autumn)

London, UK - October 18-20, 2016
Presentation

Live events in the digital age: Case Study of a catalyst for building integrated and sustained engagement with healthcare professionals

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Digital & Technology
Availability: FREE
  • The problem: High investment with limited reach and high output that is short-lived.
  • The objective: Capitalising on events to extend the value through sustained targeted engagement.
  • The strategy: An end-to-end programme designed to be multicontent, multi-event & multi-channel.
  • The evidence: Research and metrics that supports this approach and better outcomes.
Speaker

Tiberio Catania
Commercial Director
EPG Health Media, UK

Presentation

Breaking the “fail-cycle” of KOL CRM Solutions

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Digital & Technology
Availability: FREE

A plethora of studies suggest that an astonishing 50 – 75% of all CRM implementations fail in some form. So we started our KOL CRM development programme with the assumption “why should ours be any different?” Our two-year case study highlights the many challenges we (vendor & our clients) encountered in the medical affairs context, our many failings, and the innovations we built to overcome them. We’ll also present a simple framework for Medical Affairs to help maximise the success of CRM implementations to boost external expert management.

Speaker

Sanjay Singhvi
Director, System Analytic, UK

Presentation

Case study review: Leveraging technology to enhance KOL & stakeholder engagement

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Digital & Technology
Availability: FREE
  • Assessment of viable online solutions to KOL stakeholder engagement in the pharmaceutical industry.
  • Review major pharmaceutical company cases using web-based engagement solutions.
  • Understand a variety of KOL engagement scenarios, shared learnings and best organisation practices for success.
Speaker

Peter Gannon
SVP Business Partnerships, Within3, Inc.

Presentation

Fit-for-purpose process and technology to support observational research

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Availability: FREE
Speaker

Jane Turner
Executive Director of Late Phase Research, INC Research, UK

Presentation

Successfully integrating EHR and EDC data

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Clinical, IT & Big Data, Global (non-specific)
Availability: FREE
  • How companies can successfully navigate the EHR and secondarydata landscape.
  • Designing and implement studies that reap the benefits of combining EDC and EHR data to answer key questions.
  • Transforming the theory of real-world hybrid studies into reality.
Speaker

Angela Vinken
Sr. Director Observational Research
Parexel, Netherlands

Presentation

Hybrid studies: Combining different data sources to answer clinical and economic research needs

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Global (non-specific)
Availability: FREE
  • Real-world data sources: What information needs can they address?
  • Considerations, potential challenges and solutions.
  • Types of hybrid studies with case studies.
  • Chart reviews with additional data collection from patients.
  • Recruitment of patients from registries for burden of disease outcomes.
  • Linkage of different types of registries with the addition of patient interviews.
Speakers

William C. Maier
Chief Scientific Officer, Mapi Group, UK

Jennifer Eriksson
Associate Director, Real World Strategy & Analytics
Mapi Group, Sweden

Presentation

Compassionate use programs as a strategy for market access

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific), Patient-Centricity & Care
Availability: FREE
  • Why and when to run them?
  • Benefits and pitfalls.
  • Strategic considerations.
  • Case study: The French ATU programme.
Speaker

Alexandre Malouvier
Director of Scientific Affairs, Late Phase Services
PRA Health Sciences

Presentation

How digital medical communications can support a global medical affairs strategy: Opportunities and compliance considerations

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Global (non-specific)
Availability: FREE
Speakers

Rob Barker
CEO, Succinct Medical Communications, UK

James Turnbull
Digital Technical Director, Succinct Medical Communications, UK